Liberum Biotech
PrivateLast Round
Seed
Jul 24, 2023
Total Funding Raised
$2.05M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Liberum Biotech operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in July 2023.
Liberum Biotech is a biotechnology company that provides a cell-free protein synthesis platform to accelerate protein and antibody discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Liberum Biotech Comparables
Compare Liberum Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tierra Biosciences | 90% | |
| Adaptyv Bio | 84% | |
| LenioBio | 81% |
For institutional investors. Book with your work email.
Liberum Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 24, 2023 | ||||
| Accelerator | Jun 11, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Liberum Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TechU Ventures | Seed |
| Creative Destruction Lab | Accelerator |
| Velocity | Accelerator |
| IndieBio | Accelerator |
| Savantus Ventures | Seed |
| SOSV | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2026
Open roles increased to 4, 57% of headcount.
- Oct 6, 2026
Job postings increased from 0 to 4 roles, representing 57% of headcount.
For institutional investors. Book with your work email.
Liberum Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Liberum Biotech's valuation, stock price, and market status.
Is Liberum Biotech a public or private company?
Liberum Biotech is a private company.
What is the current stock price of Liberum Biotech?
Liberum Biotech is a private company, so its shares have no public market price. Caplight tracks Liberum Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Liberum Biotech worth (valuation)?
Valuation information for Liberum Biotech is not publicly available.
Can I buy Liberum Biotech stock?
Liberum Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Liberum Biotech's last funding round?
Liberum Biotech's most recent funding round was Seed on July 24, 2023.
Who are the main investors in Liberum Biotech?
Key investors in Liberum Biotech include TechU Ventures, IndieBio.
Will Liberum Biotech IPO soon?
No public IPO plans have been announced for Liberum Biotech.
How can I track Liberum Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Liberum Biotech's shares on secondary markets.